Mini-Monomer Cassette for Direct Promoter Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying promoter sequences, RNA stability modifiers, and transcriptional modifying sequences are inefficient as they do not allow for the cloning or evaluation of cloned promoters and often require indirect identification through expressed sequence tags, lacking the ability to directly recover functional sequences from eukaryotic or random DNA sources.

Innovation Solution

A DNA plasmid construct featuring a mini-monomer cassette with ribozyme cleavage sites and a catalytic core, along with a multiple cloning site and primer annealing polynucleotides, allows for the transcription, self-cleavage, and circularization of RNA transcripts, enabling the direct identification and recovery of functional promoters and modifying sequences through reverse transcription and PCR.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If computer annotation of sequenced genomes is used to identify promoter sequences, then promoter sequences can be identified through bioinformatics analysis, but the method does not allow for cloning or evaluation of the identified promoters and cannot directly recover functional sequences

Engineering Contradiction:
Improvepromoter sequence identification accuracyVSAvoidcloning and functional evaluation capability
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The method segments the identification process into two distinct phases: (1) in silico prediction using computer annotation to identify candidate promoter sequences, and (2) in vitro functional validation through cloning into reporter constructs. This segmentation allows each phase to optimize for its specific purpose while collectively achieving both accurate identification and functional verification.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an intermediary step between computational prediction and functional analysis: the cloning of predicted promoter sequences into reporter gene constructs. This intermediary allows the transition from in silico data to in vitro functional evaluation, enabling direct recovery and testing of candidate promoters while maintaining the efficiency of computational screening.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of information

If indirect identification through expressed sequence tags is used, then promoter regions can be located based on transcription start sites, but the method lacks the ability to directly recover and evaluate functional promoter sequences

Engineering Contradiction:
Improvepromoter sequence recoveryVSAvoidfunctional promoter identification accuracy
Core Design Contradiction:
Loss of informationVSMeasurement precision

Solution Approach 1:

The method merges two complementary approaches: (1) indirect identification through expressed sequence tags to locate promoter regions based on transcription start sites, and (2) direct recovery of functional sequences through cloning and reporter assays. This combination retains the advantages of both methods while overcoming their individual limitations.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent performs preliminary computational analysis and EST-based localization before conducting functional cloning experiments. This preliminary action narrows down the search space to high-probability candidate regions, making the subsequent direct recovery and functional evaluation more efficient and accurate.

Inventive Principle:
Principle #10Preliminary action

3Manufacturing precision

If upstream sequence determination is required for promoter identification, then complete promoter context can be obtained, but the process becomes more complex and time-consuming

Engineering Contradiction:
Improvepromoter sequence completenessVSAvoididentification process duration
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The method applies partial action by determining only the essential upstream sequences required for functional promoter activity rather than obtaining complete genomic context. Through systematic truncation and deletion analysis, the approach identifies the minimal functional elements needed, reducing time and complexity while maintaining identification accuracy.

Inventive Principle:
Principle #16Partial or excessive action

Solution Approach 2:

The patent employs a dynamic, iterative approach to upstream sequence determination: starting with larger upstream regions and progressively truncating to identify minimal functional elements. This dynamic strategy adapts the sequencing effort to the actual functional requirements, avoiding unnecessary analysis of non-functional regions and reducing overall process time.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the straightforward identification and recovery of functional promoters and modifying sequences, bypassing the need for upstream sequence determination and allowing for in vivo or in vitro expression, with deep sequencing analyzing the relative strength of recovered sequences.

Implementation Method 1

a mini-monomer cassette, comprising a first ribozyme cleavage site and a second ribozyme cleavage site, and comprising between the first ribozyme cleavage site and the second ribozyme cleavage site: (i) a ribozyme catalytic core

Methodology Applied
Scientific EffectRibozyme catalysis: Enzyme

Implementation Method 2

reverse transcriptase polymerase chain reaction (RT-PCR) primer annealing polynucleotides

Methodology Applied
Scientific EffectReverse transcription: Enzyme

Data Source

PatentUS12049623B2Compositions and methods for identifying polynucleotides of interest
Publication Date: 2024.07.30 RGT UNIV OF CALIFORNIA
  • US12049623B2 patent drawing
  • US12049623B2 patent drawing
  • US12049623B2 patent drawing

AI summary

Provided are constructs and methods useful for the screening and identification of polynucleotide sequences of interest, in particular promoters, RNA stability modifying sequences and transcriptional modifying sequences.